Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen

Purpose of the study. Evaluation of the diagnostic characteristics of the CA‑62 marker for epithelial carcinomas for detecting early‑stage prostate cancer in a double‑blind clinical study. This study is also focused on the possibility of using the CA‑62 antigen as an auxiliary tool for decision‑maki...

Full description

Saved in:
Bibliographic Details
Main Authors: Zh. R. Cherkasova, S. A. Tsurkan, A. I. Prostyakova, A. M. Boroda, A. A. Rozhkov, Yu. N. Pirogova, N. M. Nikitina, M. I. Sekacheva
Format: Article
Language:Russian
Published: QUASAR, LLC 2023-03-01
Series:Исследования и практика в медицине
Subjects:
cancer marker
prostate cancer
benign prostatic hyperplasia
prostate‑specific antigen
ca‑62 cancer antigen
prostate biopsy
Online Access:https://www.rpmj.ru/rpmj/article/view/874
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items